(NR668 Week 6: 2026 Test Preparation)
Save
N
R
6
6
8
W
e
e
k
6
Page 1 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
Students
also
studied
Terms in this set (105)
Page 2 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
ADHD -long-term disorder characterized by either hyperactivity & impulsivity or
inattention
-affect the development of proper cognitive, behavioral, emotional, social,
& academic function
-Symptoms of the hyperactivity & impulsivity subtype:
• excessive fidgeting or talking, feelings of restlessness & impatience,
frequent interruption, difficultly playing quietly
• reach peak severity when the child is around 8 years of age
-symptoms of inattentive subtype
• difficulty organizing tasks, maintaining a routine, paying attention to detail
• Children may avoid tasks that are intellectually challenging, resulting in
poor academic or cognitive performance
• may not be distinguishable until 8-9 years of age
-primarily disrupts neuronal connections within the frontal lobe & prefrontal
cortex
Page 3 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
FDA approved medications for ADHD Stimulants
-Methylphenidate
• Azstaryz
• Concerta
• Focalin
• Jornay PM
• Metadate CD or ER
• Ritalin
-Amphetamine
• Adderall
• Adzenys ER or XR-ODT
• Dexedrine
• Vyvanse
Non-stimulants
-Norepinephrine reuptake inhibitors
• Strattera
• Qelbree
-Alpha agonist
• Kapvay
• Intuniv
https://chadd.org/wp-content/uploads/2021/09/ADHD-MEDICATIONS-
APPROVED-BY-THE-US-FDA-2021.pdf
Behavior Management: Parent training -What parents learn when trained in behavior therapy
• Positive Communication
• Positive Reinforcement
• Structure & Discipline
Page 4 3/30/2026, 4:48:56 PM
Save
N
R
6
6
8
W
e
e
k
6
Page 1 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
Students
also
studied
Terms in this set (105)
Page 2 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
ADHD -long-term disorder characterized by either hyperactivity & impulsivity or
inattention
-affect the development of proper cognitive, behavioral, emotional, social,
& academic function
-Symptoms of the hyperactivity & impulsivity subtype:
• excessive fidgeting or talking, feelings of restlessness & impatience,
frequent interruption, difficultly playing quietly
• reach peak severity when the child is around 8 years of age
-symptoms of inattentive subtype
• difficulty organizing tasks, maintaining a routine, paying attention to detail
• Children may avoid tasks that are intellectually challenging, resulting in
poor academic or cognitive performance
• may not be distinguishable until 8-9 years of age
-primarily disrupts neuronal connections within the frontal lobe & prefrontal
cortex
Page 3 3/30/2026, 4:48:56 PM
, (NR668 Week 6: 2026 Test Preparation)
FDA approved medications for ADHD Stimulants
-Methylphenidate
• Azstaryz
• Concerta
• Focalin
• Jornay PM
• Metadate CD or ER
• Ritalin
-Amphetamine
• Adderall
• Adzenys ER or XR-ODT
• Dexedrine
• Vyvanse
Non-stimulants
-Norepinephrine reuptake inhibitors
• Strattera
• Qelbree
-Alpha agonist
• Kapvay
• Intuniv
https://chadd.org/wp-content/uploads/2021/09/ADHD-MEDICATIONS-
APPROVED-BY-THE-US-FDA-2021.pdf
Behavior Management: Parent training -What parents learn when trained in behavior therapy
• Positive Communication
• Positive Reinforcement
• Structure & Discipline
Page 4 3/30/2026, 4:48:56 PM
